Grants / Department of Health and Human Services / National Institutes of Health

PAR-23-219: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)

Closed Closed September 5, 2025 Opportunity PAR-23-219 ☆ Save

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.

• Award amountsNot given on Grants.gov
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to small businesses.

• Small businesses

Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

More grants for small businesses.

Is this a realistic fit?

• Most of the money in the 18 programs behind this notice (70% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The NOFO aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award. Clinical Trials are not accepted under this NOFO.

Category: Education, Environment, Food and Nutrition, Health.

Other programs behind this notice

• Extramural Research Programs in the Neurosciences and Neurological Disorders 93.853
  $9.1 billion in five years
• Mental Health Research Grants 93.242
  $8.8 billion in five years
• Cancer Treatment Research 93.395
  $5.6 billion in five years
• Vision Research 93.867
  $3.4 billion in five years
• National Center for Advancing Translational Sciences 93.350
  $3.1 billion in five years
• Cancer Detection and Diagnosis Research 93.394
  $2.7 billion in five years
• Arthritis, Musculoskeletal and Skin Diseases Research 93.846
  $2.6 billion in five years
• Alcohol Research Programs 93.273
  $2.2 billion in five years
• Human Genome Research 93.172
  $2.2 billion in five years
• Environmental Health 93.113
  $2.1 billion in five years
• Research Related to Deafness and Communication Disorders 93.173
  $2.1 billion in five years
• Oral Diseases and Disorders Research 93.121
  $1.9 billion in five years
• Discovery and Applied Research for Technological Innovations to Improve Human Health 93.286
  $1.8 billion in five years
• Lung Diseases Research 93.838
  $8.7 million in five years
• Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93.840
  $3.3 million in five years

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.